The Effect of Virtual Reality Glasses on Dental Anxiety Control

Periodontitis Clinical Trial

Official title:

Evaluation of the Effect of Virtual Reality Glasses Used During Scaling and Root Planing on Dental Anxiety Control

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05038540
• Other study ID #: 00
• Status: Completed
• Phase: N/A
• Start date: October 8, 2021
• Est. completion date: December 23, 2021

Study information

• Verified date: July 2023
• Source: Kutahya Health Sciences University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

In this clinical study, it was aimed to evaluate whether there is a decrease in patient anxiety by applying virtual reality glasses, which are the product of new technology, during scaling and root planing treatment. Patients who required scaling and root planing treatment and also scored 9 or above according to the Dental Anxiety Scale were included in our study. Scaling and root planing was performed in a randomly selected intraoral quadrant of the patients, in the same way, with or without the use of virtual reality glasses. In the virtual reality glasses application, a video consisting of images of nature landscapes developed for patient rehabilitation was projected onto the screen in front of the patient's eyes. The Dental Anxiety Scale was reapplied after the completion of the treatment. In the intraoral quadrant where virtual reality glasses were used, it is expected that lower Corah Dental Anxiety Scale scores may be obtained after the treatment is completed, compared to the intraoral quadrant where the treatment is performed without glasses, thus reducing anxiety.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 60
• Est. completion date: December 23, 2021
• Est. primary completion date: November 23, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 59 Years

Eligibility

Inclusion Criteria:

• Being over 18 years old
• Being systemically healthy
• Needing treatment in at least two quadrants of the mouth
• At least five teeth in each quadrant and at least one region with a terminal pocket depth =4 mm
• Having a score of 9 or higher on the dental anxiety scale

Exclusion Criteria:

• Having a history of seizures or a convulsive disorder
• Balance disorders such as nystagmus, vertigo
• Use of psychotropic drugs
• Getting treatment for anxiety
• Presence of dermatological lesions on the face and especially around the eyes
• The presence of a lesion in the eye that will prevent the use of virtual reality glasses

Related Conditions & MeSH terms

• Anxiety Disorders
• Calculi
• Calculus, Dental
• Dental Anxiety
• Dental Calculus
• Dental Fear
• Gingivitis
• Periodontitis

Intervention

Procedure:
• Scaling and root planing
Phase 1 periodontal therapy

Locations

Country	Name	City	State
Turkey	Kutahya Health Sciences University	Kütahya

Sponsors (1)

Lead Sponsor	Collaborator
Kutahya Health Sciences University

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Lower Corah Dental Anxiety Scale scores in virtual reality application group	It is expected that lower Corah Dental Anxiety Scale scores may be obtained after the treatment is completed, compared to the intraoral quadrant where the treatment is performed without glasses, thus reducing anxiety.	Baseline
Primary	Lower blood pressure and heart rate values in virtual reality application group	It is expected that lower blood pressure and heart rate values will be obtained during and after treatment in the intraoral quadrant, where glasses are used, compared to the control quadrant.	Baseline
Secondary	Patients' feedback	It is expected that positive feedback will be received by evaluating the patients' feelings. about the glasses application with the Visual Analog Scale applied after the treatment is completed.	Baseline, 1st month
Secondary	Dentist's feedback	After the treatment, it is expected that the use of glasses in patients with anxiety will be evaluated as a viable method by taking the opinions of the physicians regarding the application.	Baseline